Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,294 papers from all fields of science
Search
Sign In
Create Free Account
LINC00914 gene
Known as:
RAGE
, LINC00914
, RNA for advanced-glycation end products
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM
E. Miranda
,
Kelly N. Z. Fuller
,
+4 authors
J. Haus
Nutrients
2019
Corpus ID: 73489478
Advanced glycation end products (AGEs) promote the development of diabetic complications through activation of their receptor…
Expand
2018
2018
Ketamine alleviates LPS induced lung injury by inhibiting HMGB1-RAGE level.
Y. Zhang
,
M. Zhang
,
C.-Y. Wang
,
A. Shen
European Review for Medical and Pharmacological…
2018
Corpus ID: 4717876
OBJECTIVE Inflammatory cytokines secretion is an important reason to promote lung tissue inflammation in acute lung injury (ALI…
Expand
2015
2015
The Possible Involvement of HLA Class III Haplotype (RAGE, HSP70 and TNF Genes) in Alzheimer's Disease.
Chiara Boiocchi
,
Elisa Maggioli
,
+5 authors
M. Cuccia
Current Alzheimer Research
2015
Corpus ID: 43290089
In the central nervous system Hsp70s seems to have a protective role in repair and removal of cellular proteins damaged by stress…
Expand
2014
2014
RAGE, Receptor of Advanced Glycation Endoproducts, Negatively Regulates Chondrocytes Differentiation
Tatsuya Kosaka
,
Rino Fukui
,
+7 authors
T. Fujita
PLoS ONE
2014
Corpus ID: 531791
RAGE, receptor for advanced glycation endoproducts (AGE), has been characterized as an activator of osteoclastgenesis. However…
Expand
2010
2010
MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells.
Y. Sakuraoka
,
T. Sawada
,
+8 authors
K. Kubota
World Journal of Gastroenterology
2010
Corpus ID: 21009451
AIM To investigate the proliferative effect of advanced glycation end-products (AGEs) and the role of their cellular receptor…
Expand
2010
2010
Association of biochemical parameters and RAGE gene polymorphisms in healthy infants and their mothers.
Peter Boor
,
Peter Boor
,
+7 authors
Katarína Šebeková
Clinica chimica acta; international journal of…
2010
Corpus ID: 19723530
2010
2010
[Expression of RECK, RAGE and MMP-9 in nasopharyngeal carcinoma and its significance].
Ronghua Li
,
yanfei deng
Lin chuang er bi yan hou tou jing wai ke za zhi…
2010
Corpus ID: 44820778
OBJECTIVE To investigate the expression and the relativity of RECK,RAGE and MMP-9 in nasopharyngeal carcinoma (NPC) tissues…
Expand
2009
2009
Targeted resequencing of two genes, RAGE and POLL, confirms findings from a genome-wide scan for adaptive evolution and provides evidence for positive selection in additional populations.
Joanna L. Kelley
,
Kayley Turkheimer
,
Margo Haney
,
W. Swanson
Human Molecular Genetics
2009
Corpus ID: 7632026
The availability of multiple genome-wide human polymorphism datasets has led to an increase in efforts to scan the genome for…
Expand
2002
2002
Tumor-associated Antigens as Possible Targets for Immune Therapy in Head and Neck Cancer: Comparative mRNA Expression Analysis of RAGE and GAGE Genes
K. Götte
,
Dirk Usener
,
F. Riedel
,
K. Hörmann
,
D. Schadendorf
,
S. Eichmüller
Acta Oto-Laryngologica
2002
Corpus ID: 7087339
Specific immune therapy targeting residual areas of cancer cells may emerge as a powerful treatment strategy for head and neck…
Expand
1999
1999
Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes.
K. Kaňková
,
A. Vašků
,
D. Hájek
,
J. Záhejský
,
V. Vašků
Diabetes Care
1999
Corpus ID: 38359016
Novel polymorphism G82S in the gene encoding RAGE have been identified. The association of the G82S with skin complications in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE